| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-08 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |